Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Enveric Biosciences Inc logo

Enveric Biosciences Inc

Sector: Manufacturing   

Industry: Semiconductor and Related Device Manufacturing

1.47
 
USD
  
0.02
  
(1.38%)
Optionable: Yes  Market Cap: 3 M  90-day average vol: 19,590

Previous close: 1.45  Open: 1.47  Bid: 1.39  Ask: 1.57
52 week range    
1.30   
   6.98
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Wednesday 29th November 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

ENVB Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock295976.0
AccruedPreferredStockDividends2 M3 M426003.033014.0
AcquiredInProcessRnD-32811.0
AcquisitionExpense333237.0
Amortization-1 M-3 M-3 M-68453.0-409503.0-643333.0-168750.0
Amortization of intangibles-1 M-3 M-3 M0.0-120872.0-643333.0-168750.0
Basic EPS from continuing operations-10.5-41.0-141.5-59.5-103.5-13.0
Basic EPS total-10.5-37.5-41.0-141.5-59.5-103.5-13.0
Basic weighted shares outstanding242840.0242840.015 M261371.0299655.0475800.042576.0115071.0472342.01 M
Cost of sales-29 M-38 M
Depletion32 M
Depreciation1 M3 M3 M2 M120872.0656643.0327910.0
Depreciation unreconciled1 M3 M3 M34 M120872.0656643.0327910.0
DepreciationAndAmortization1 M3 M3 M2 M120872.0656643.0327910.0
Diluted EPS total-10.5-37.5-41.0-141.5-59.5-103.5-13.0
Diluted normalized net income/share-10.5-41.0-141.5
Diluted weighted shares outstanding261371.0299655.0475800.042576.0115071.0472342.01 M
Earnings from equity interest-410817.0
EarningsFromEquityInterestNetOfTax-410817.0
Fees-34 M
GainOnSaleOfPPE1289.0
GainOnSaleOfSecurity-22690.03 M
GeneralAndAdministrativeExpense22690.0-27211.0-32811.0-220000.0-340000.011 M2 M5 M20 M12 M
Gross operating profit28500.07 M10 M9 M40 M
ImpairmentOfCapitalAssets9 M39 M7 M
Income before tax-22690.01289.0-32811.0-7 M-11 M-11 M-2 M-7 M-56 M-20 M
Income restructuring and M&A2 M-400000.0
Income taxes1931.01450.0833.0-4 M-2 M6 M0.0-5 M-7 M-1 M
Interest income-410817.01 M
InterestExpenseNonOperating751074.0575039.0729896.081823.0445250.010316.05249.0
InterestExpenseOperating-13370.00.0
InterestIncomeOperating0.0
MinorityInterests-3382.0
MiscOtherSpecialCharges29789.0-32811.016604.04995.0-3 M32316.0-802109.08 M4 M
Net income from total operations-24621.055550.0-833.0-3 M-9 M-17 M-2 M-7 M-49 M-18 M
NetIncomeCommonStockholders-24621.055550.0-833.0-3 M-11 M-19 M-2 M-7 M-49 M-19 M
NetIncomeContinuousOperations-24621.055550.0-833.0-3 M-9 M-17 M-2 M-7 M-49 M-18 M
NetIncomeExtraordinary-3 M
NetNonOperatingInterestIncomeExpense-1 M-575039.0-729896.0-81823.0-445250.0-10316.0-5249.0
Operating income-22690.027211.032811.0-4 M-10 M2 M-2 M-6 M-26 M-20 M
Operating income before depreciation (EBITDA)-22690.01289.0-32811.0-4 M-8 M-7 M-2 M0.0-56 M-20 M
OperatingExpense22690.0-27211.0-32811.0-12 M-21 M7 M2 M6 M26 M20 M
Other income net22690.0-29789.032811.02 M476128.03 M-32316.0802109.0-8 M-7 M
OtherGandA22690.0-27211.0-32811.0-220000.0-340000.011 M2 M5 M20 M12 M
OtherImpairmentOfCapitalAssets-900000.00.00.01 M
OtherOperatingExpenses-1 M-7 M
OtherWriteOff34 M
OtherunderPreferredStockDividend2 M3 M426003.0328990.0
PreferredStockDividends2 M3 M426003.0328990.0
RentAndLandingFees22690.0-27211.0-32811.0-220000.0-340000.0-260000.00.00.0-30586.0-120667.0
Research & development expense-55104.0174083.05 M8 M
ResearchExpense174083.05 M8 M
RestructringAndMnAIncome2 M-400000.0
SalariesAndWages-1 M-7 M-2 M
Selling Gen & administrative expense22690.0-27211.0-32811.09 M19 M11 M2 M5 M20 M12 M
SellingAndMarketingExpense9 M19 M
SellingExpense9 M19 M
Special income/charges-32811.0-2 M400000.0-9 M-39 M-7 M
Total Income available for interest expense (EBIT)-22690.01289.0-32811.0-6 M-11 M-10 M-2 M0.0-56 M-20 M
Total common shares outstanding137.0175.015 M2915.03758.09405.016233.0389010.01 M2 M
Total net income-24621.055550.0-833.0-3 M-9 M-17 M-2 M-7 M-49 M-18 M
Total ordinary shares2 M2 M2 M2 M2 M2 M2 M2 M2 M2 M
Total revenues28500.036 M49 M43 M40 M
TotalExpenses22690.0-27211.0-32811.0-42 M-59 M7 M2 M6 M26 M20 M
TotalRevenue28500.036 M49 M9 M40 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today